Literature DB >> 23612081

Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9).

Shuihua Lu1, Xiuhong Xi, Yufang Zheng, Ye Cao, Xinian Liu, Hongzhou Lu.   

Abstract

Avian influenza is one of the most dangerous contagions in poultry worldwide, and avian influenza A viruses are the major pathogens responsible. Outbreaks of H7N9, a strain of the avian influenza A virus H7 subtype, have increasingly been reported in several countries since 2007. This spring, H7N9 broke out in China and has thus far caused 24 cases of infection and 7 deaths. Recently, we treated two patients with H7N9 infection. The infection was characterized by respiratory symptoms, fever, rapid progression, and significant hypoxemia. Laboratory tests showed a low level or decrease in leukocytes, a drop in blood platelets, and an increase in myocardial enzymes and aspartate aminotransferase. Oseltamivir, anti-infective drugs, and immunoglobulin were administered. Supplemental oxygen or non-invasive mechanical ventilation helped to relieve symptoms. This report provides information on the clinical characteristics and treatment of two Chinese patients with H7N9.

Entities:  

Mesh:

Year:  2013        PMID: 23612081

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  21 in total

1.  H7N9 influenza-the laboratory presentations: a letter to editor.

Authors:  Viroj Wiwanitkit
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

Review 2.  The pandemic potential of avian influenza A(H7N9) virus: a review.

Authors:  W D Tanner; D J A Toth; A V Gundlapalli
Journal:  Epidemiol Infect       Date:  2015-07-24       Impact factor: 4.434

3.  An overview of the characteristics of the novel avian influenza A H7N9 virus in humans.

Authors:  Kei-Xian Tan; Sabrina A Jacob; Kok-Gan Chan; Learn-Han Lee
Journal:  Front Microbiol       Date:  2015-03-05       Impact factor: 5.640

Review 4.  H7N9 Influenza: The Emerging Infectious Disease.

Authors:  Viroj Wiwanitkit
Journal:  N Am J Med Sci       Date:  2013-07

5.  Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.

Authors:  Christopher J Woods; Maturos Malaisree; Ben Long; Simon McIntosh-Smith; Adrian J Mulholland
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

6.  Comparison of characteristics between patients with H7N9 living in rural and urban areas of Zhejiang Province, China: a preliminary report.

Authors:  Jimin Sun; Zhenyu Gong; Huakun Lv; Zhiping Chen; Chengliang Chai; Shelan Liu; Feng Ling; Ye Lu; Jian Cai; Zhao Yu; Ziping Miao; Jiangping Ren; Enfu Chen
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

Review 7.  Prevalence and control of H7 avian influenza viruses in birds and humans.

Authors:  E M Abdelwhab; J Veits; T C Mettenleiter
Journal:  Epidemiol Infect       Date:  2014-01-15       Impact factor: 4.434

8.  Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.

Authors:  Amber Farooqui; Linxi Huang; Suwu Wu; Yingmu Cai; Min Su; Pengzhou Lin; Weihong Chen; Xibin Fang; Li Zhang; Yisu Liu; Tiansheng Zeng; Stephane G Paquette; Adnan Khan; Alyson A Kelvin; David J Kelvin
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

9.  Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus.

Authors:  Yan-Ling Wu; Li-Wen Shen; Yan-Ping Ding; Yoshimasa Tanaka; Wen Zhang
Journal:  Int J Biol Sci       Date:  2014-01-09       Impact factor: 6.580

10.  Inhibition of influenza H7 hemagglutinin-mediated entry.

Authors:  Aleksandar Antanasijevic; Han Cheng; Duncan J Wardrop; Lijun Rong; Michael Caffrey
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.